Ads

 

Ads

 

Ads

 

World Top 100 Pharmaceutical Companies List by Market Cap as of August 2026

World Top 100 Pharmaceutical Companies List by Market Cap as of August 2026, World Biggest 100 Pharmaceutical Companies by Market Cap, World Largest 100 Pharmaceutical Companies in the World by market cap as of August 2026.

Metatag Title
World Top Pharmaceutical Companies in 2026
Metatag Abstract
World Top Pharmaceutical Companies by Market Cap in 2026, World Largest Pharmaceutical Companies by Market Cap in 2026.
  1. Asymchem Laboratories (Tianjin)

    World Rank (Aug-2026)
    2,437
    Market Cap (Aug-2026)
    8.723 Billion USD
    World Rank (Jan-05-2024)
    2,720
    Market Cap (Jan-05-2024)
    5.496 Billion USD
    World Rank (Jul-30-2023)
    2,458
    Market Cap (Jul-30-2023)
    6.228 Billion USD
    World Rank (Dec-25-2022)
    2,100
    Market Cap (Dec-25-2022)
    6.769 Billion USD
    World Rank (Jan-07-2022)
    1,418
    Market Cap (Jan-07-2022)
    14.21 Billion USD
    Annual Revenue in USD
    1,437 Million USD
    Annual Operating Income in USD
    445 Million USD
    Annual Net Income in USD
    463 Million USD
    Annual Results for Period Ending
    Dec-2022 ending period
    Headquarters Country
    Company Profile
    Asymchem is a Pharmaceutical company. The company range from early clinical stage to commercial stage including R&D (Research and development) and cGMP(Current Good Manufacturing Practice) production of advanced intermediates, APIs (Application Programming Interface), formulations as well as clinical research services. It is having 3,840 employees as on 2019. The headquarters is in China.
  2. Reata Pharmaceuticals

    World Rank (Aug-2026)
    2,443
    World Rank (Jan-05-2024)
    2,443
    World Rank (Jul-30-2023)
    2,443
    Market Cap (Jul-30-2023)
    6.278 Billion USD
    World Rank (Dec-25-2022)
    7,125
    Market Cap (Dec-25-2022)
    1.319 Billion USD
    World Rank (Jan-07-2022)
    9,134
    Market Cap (Jan-07-2022)
    1.05 Billion USD
    Annual Revenue in USD
    2 Million USD
    Annual Net Income in USD
    -312 Million USD
    Annual Results for Period Ending
    For year ending December-2022
    Headquarters Country
    Company Profile

    Reata Pharmaceuticals is a Bio-pharmaceutical company with headquarters is in Texas, USA.

    Biogen acquired Reata Pharmaceuticals for 7.3 Billion USD in 2023.

  3. Eisai

    World Rank (Aug-2026)
    2,453
    Market Cap (Aug-2026)
    8.647 Billion USD
    World Rank (Jan-05-2024)
    1,230
    Market Cap (Jan-05-2024)
    14.345 Billion USD
    World Rank (Jul-30-2023)
    995
    Market Cap (Jul-30-2023)
    18.227 Billion USD
    World Rank (Dec-25-2022)
    881
    Market Cap (Dec-25-2022)
    18.732 Billion USD
    World Rank (Jan-07-2022)
    1,258
    Market Cap (Jan-07-2022)
    16.12 Billion USD
    Annual Revenue in USD
    5,273 Million USD
    Annual Operating Income in USD
    284 Million USD
    Annual Net Income in USD
    393 Million USD
    Annual Results for Period Ending
    Mar-2023 ending year
    Headquarters Country
    Stock Category
    Company Profile

    Eisai is Pharmaceutical and Healthcare Products company with headquarters is in Tokyo, Japan.

    Facts About Company

    For year ending March-2023, Eisai annual revenue was 744 billion JPY, annual operating income was 40 billion JPY and annual net income was 55.4 billion JPY.

    Eisai had 11,076 employees as on 2023.

    It had 15 Drug Discovery, Research and Development, and Clinical Research Sites and 9 Production sites.

  4. Kyowa Kirin

    World Rank (Aug-2026)
    2,474
    Market Cap (Aug-2026)
    8.521 Billion USD
    World Rank (Jan-05-2024)
    1,811
    Market Cap (Jan-05-2024)
    8.943 Billion USD
    World Rank (Jul-30-2023)
    1,644
    Market Cap (Jul-30-2023)
    10.251 Billion USD
    World Rank (Dec-25-2022)
    1,297
    Market Cap (Dec-25-2022)
    12.269 Billion USD
    World Rank (Jan-07-2022)
    1,412
    Market Cap (Jan-07-2022)
    14.25 Billion USD
    Annual Revenue in USD
    2,822 Million USD
    Annual Operating Income in USD
    584 Million USD
    Annual Net Income in USD
    380 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Stock Category
    Company Profile
    Kyowa Kirin is a company that develops, manufactures, and markets pharmaceuticals. The Company produces anti-allergic agent, treating hypertension and angina pectoris agent, ulcerative colitis agent, anti-epileptic agent, and more. The headquarters is in Japan.
  5. Tongwei

    World Rank (Aug-2026)
    2,517
    Market Cap (Aug-2026)
    8.326 Billion USD
    World Rank (Jan-05-2024)
    1,147
    Market Cap (Jan-05-2024)
    15.526 Billion USD
    World Rank (Jul-30-2023)
    858
    Market Cap (Jul-30-2023)
    21.798 Billion USD
    World Rank (Dec-25-2022)
    692
    Market Cap (Dec-25-2022)
    24.480 Billion USD
    World Rank (Jan-07-2022)
    708
    Market Cap (Jan-07-2022)
    29.70 Billion USD
    Annual Revenue in USD
    19,925 Million USD
    Annual Operating Income in USD
    6,027 Million USD
    Annual Net Income in USD
    3,599 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    TONGWEI has business in agriculture related and animal feeds producing company. Headquarters is in China.

  6. Alk-Abello A/S

    World Rank (Aug-2026)
    2,522
    Market Cap (Aug-2026)
    8.308 Billion USD
    World Rank (Jan-05-2024)
    4,133
    Market Cap (Jan-05-2024)
    3.246 Billion USD
    World Rank (Jul-30-2023)
    5,183
    Market Cap (Jul-30-2023)
    2.344 Billion USD
    World Rank (Dec-25-2022)
    4,071
    Market Cap (Dec-25-2022)
    3.007 Billion USD
    World Rank (Jan-07-2022)
    3,110
    Market Cap (Jan-07-2022)
    5.34 Billion USD
    Annual Revenue in USD
    580 Million USD
    Annual Net Income in USD
    32 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    ALK-Abello A/S is a Pharmaceutical company. The headquarters is in Denmark.
  7. Rhythm Pharmaceuticals

    World Rank (Aug-2026)
    2,615
    Market Cap (Aug-2026)
    7.951 Billion USD
    World Rank (Jan-05-2024)
    4,844
    Market Cap (Jan-05-2024)
    2.594 Billion USD
    World Rank (Jul-30-2023)
    8,637
    Market Cap (Jul-30-2023)
    1.018 Billion USD
    World Rank (Dec-25-2022)
    6,150
    Market Cap (Dec-25-2022)
    1.648 Billion USD
    World Rank (Jan-07-2022)
    13,819
    Market Cap (Jan-07-2022)
    0.47 Billion USD
    Annual Revenue in USD
    190 Million USD
    Annual Operating Income in USD
    -192 Million USD
    Annual Net Income in USD
    -197 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile
    Rhythm is a Biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic diseases of obesity. The headquarters is in USA.
  8. Eidos Therapeutics

    World Rank (Aug-2026)
    2,624
    World Rank (Jan-05-2024)
    2,624
    World Rank (Jul-30-2023)
    2,624
    World Rank (Dec-25-2022)
    2,624
    World Rank (Jan-07-2022)
    2,624
    Annual Revenue in USD
    27 Million USD
    Annual Operating Income in USD
    -40 Million USD
    Annual Net Income in USD
    -38 Million USD
    Annual Results for Period Ending
    For year ending December-2019
    Headquarters Country
    Company Profile

    Eidos Therapeutics is a Biopharmaceutical company with headquarters is in California, USA.

    Eidos Therapeutics was acquired by BridgeBio Pharma Inc in 2021.

     

  9. Grifols S.A.

    World Rank (Aug-2026)
    2,630
    Market Cap (Aug-2026)
    7.879 Billion USD
    World Rank (Jan-05-2024)
    1,723
    Market Cap (Jan-05-2024)
    9.535 Billion USD
    World Rank (Jul-30-2023)
    1,788
    Market Cap (Jul-30-2023)
    9.235 Billion USD
    World Rank (Dec-25-2022)
    2,512
    Market Cap (Dec-25-2022)
    5.513 Billion USD
    World Rank (Jan-07-2022)
    1,735
    Market Cap (Jan-07-2022)
    11.02 Billion USD
    Annual Revenue in USD
    6,685 Million USD
    Annual Operating Income in USD
    774 Million USD
    Annual Net Income in USD
    229 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Stock Category
    Company Profile

    Pharmaceutical and healthcare company with headquarters is in Barcelona, Spain.

  10. Richter Gedeon Vegyeszeti Gyar Nyilvanosan Mukodo

    World Rank (Aug-2026)
    2,712
    Market Cap (Aug-2026)
    7.550 Billion USD
    World Rank (Jan-05-2024)
    2,938
    Market Cap (Jan-05-2024)
    4.970 Billion USD
    World Rank (Jul-30-2023)
    3,151
    Market Cap (Jul-30-2023)
    4.687 Billion USD
    World Rank (Dec-25-2022)
    3,044
    Market Cap (Dec-25-2022)
    4.392 Billion USD
    World Rank (Jan-07-2022)
    3,270
    Market Cap (Jan-07-2022)
    5.03 Billion USD
    Annual Revenue in USD
    2,269 Million USD
    Annual Operating Income in USD
    538 Million USD
    Annual Net Income in USD
    439 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    RICHTER GEDEON VEGYESZETI GYAR NYILVANOSAN MUKODO is a Specialty Pharmaceutical company focused on therapies across a number of cardiovascular diseases there is an increased demand to osteoporosis and rheumatic diseases. The headquarters is in Hungary.

Share

Ads